At CFO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top Vaud based CFO’ operating in the Biotechnology space. If you think a CFO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
CFO of AB2 Bio
Follow Fernando Cunha:
About AB2 Bio: AB2 Bio is a drug discovery and development company.
SVP – Chief Financial Officer of SOPHiA GENETICS
Valentin Matillon joined SOPHiA GENETICS in 2018 as Chief Financial Officer. He is a seasoned finance executive with over 20 years of leadership experience in IT, Telecommunications and MedTech companies. He has held a number of senior finance management positions at SITA, Electronic Arts and Hewlett-Packard, including Group CFO, senior finance director in charge of corporate finance, financial planning & analysis, and performance management programs. Most recently, as senior finance director at the Hobart Group, Valentin led the corporate finance, financing & accounting operations team. As CFO, Valentin focuses on increasing shareholder value by driving global financial excellence and long-term sustainability. In addition to leading the Finance organization, Valentin is also in charge of the Legal department and Business Development activities. He received his Finance B.A. from Institut des Hautes Etudes Economiques et Commerciales de Paris and his MS from Ecole Centrale de Paris, France. “It is not the strongest of the species that survives, but the most adaptable” – Charles Darwin
Follow Valentin Matillon:
About NOVIGENIX, SOPHiA GENETICS: SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
Partner and Chief Financial Officer of NuChem Sciences
Patrick Montpetit has over fifteen years of experience in senior financial management positions. He is a chartered accountant, specializing in corporate finance and has extensive experience in the life sciences and biopharmaceutical industries. Prior to joining Immunotec, Mr. Montpetit served as Vice-President, Finance and Chief Financial Officer of Bioniche Life Sciences Inc. and Director of Finance, Administration, Commercial Agreements and Alliances with DSM Biologics Inc. His professional experience includes serving as Chairman of the Quebec Biotechnology Association and Director of the Montreal InVivo organization.
Follow Patrick Montpetit:
About NuChem Sciences: NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal.
CFO of Stilla Technologies
Follow Khaled Bahi:
About Stilla Technologies: Stilla Technologies is a Paris-based european biotechnology company.
CFO of Novaton
Follow Marco Pizzichini:
About Novaton: Novaton develops and sells clean tech systems for the aquaculture industry.